ninhydrin has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flatt, PR; McClenaghan, NH; McCluskey, JT; Picton, SF | 1 |
| Bailey, CJ; Flatt, PR; Freytag, S; Lenzen, S; Panten, U | 1 |
2 other study(ies) available for ninhydrin and Pancreatic Neoplasms
| Article | Year |
|---|---|
Effects of cytotoxic agents on functional integrity and antioxidant enzymes in clonal beta-cells.
Topics: Alloxan; Animals; Apoptosis; Cell Line; Cytotoxins; Dose-Response Relationship, Drug; Hydrogen Peroxide; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Ninhydrin; Pancreatic Neoplasms; Rats; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Tumor Cells, Cultured | 2002 |
Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells.
Topics: Alloxan; Animals; Dithiothreitol; Hexokinase; Indenes; Insulin; Insulin Secretion; Islets of Langerhans; Kidney; Liver; Mice; Mice, Inbred Strains; Ninhydrin; Pancreatic Neoplasms; Tumor Cells, Cultured | 1990 |